Guardian Bio

Guardian Bio YC 지원서

Summer 2022Active

Guardian Bio은(는) Summer 2022 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치
Summer 2022
산업
HealthcareTherapeutics
팀 규모
2
상태
Active
출시됨
2022

창업자

  • Ananya Zutshi
    Ananya ZutshiFounder
  • Ricky Barrett
    Ricky BarrettFounder

Guardian Bio의 사업 내용

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Guardian Bio의 YC 지원서, 재구성됨

Y Combinator 지원

Guardian Bio, Summer 2022 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Guardian Bio

Describe what your company does in 50 characters or less.

Dendritic cell-based platform for cancer therapy

What is your company going to make? Please describe your product and what it does or will do.

We create a dendritic cell therapy for cancer patients. Our product takes stem cells from a patient, turns them into therapeutic dendritic cells trained to recognize that patient's tumor, and puts them back to activate the immune system to fight cancer.

Where do you live now, and where would the company be based after YC?

We currently live in Boston, MA, and the company will be based there after YC as well.

Explain your decision regarding location.

Boston is a hub for biotech and medical research with access to leading hospitals and academic collaborators, which is critical for our work developing cellular therapies.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

자주 묻는 질문

Guardian Bio의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Guardian Bio의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Guardian Bio과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.

Guardian Bio은(는) 어떤 YC 배치에 있었나요?

Guardian Bio은(는) Y Combinator Summer 2022 배치에 참여했습니다.

Guardian Bio은(는) 누가 설립했나요?

Guardian Bio은(는) Ananya Zutshi, Ricky Barrett(이)가 설립했습니다.

Guardian Bio은(는) 무엇을 하나요?

Dendritic cell-based platform for cancer therapy

전체 재구성된 지원서를 어떻게 읽나요?

무료 Round Funded 계정을 만드세요. Guardian Bio의 전체 26개 질문 버전 지원서와 모든 YC 배치 지원서는 YC Insights에서 확인할 수 있습니다.

Guardian Bio과(와) 같은 다른 YC 스타트업